News

While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...
Jack Daniel's is losing ground as Americans turn to cannabis, weight-loss drugs, and Gen Z snubs liquor. Discover why whiskey ...
Last week, shares of beverage group Brown-Forman plummeted by more than 18% after the company forecast a decline in annual ...
Weight-loss jabs may have to be used for many years if the long-term benefits to patients and health care systems are to be ...
More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in their food and beverage preferences ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
In the UK, anxiety, panic attacks and insomnia are not listed as possible side-effects for Ozempic, Wegovy or Mounjaro.
Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...
WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...
A Slimming World Consultant with over 11 years’ experience from Bedford says slimming clubs are needed more than ever despite ...